Ectopic expression of p27(Kip1) in oligodendrocyte progenitor cells results in cell-cycle growth arrest

Journal of Neurobiology

Volumn 36, Issue 3, 1998, Pages 431-440

  Tikoo, Ravi ^a   Osterhout, Donna J ^b   Casaccia Bonnefil, Patrizia ^b   Seth, Prem ^c   Koff, Andrew ^d   Chao, Moses V ^b  

^a Department of Obstetrics Gynecology   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cell cycle; Cyclin dependent kinase; Differentiation; Oligodendrocyte

Indexed keywords

PROTEIN P27; ANTIMETABOLITE; BROXURIDINE; CDK2 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DIAGNOSTIC AGENT; HISTONE H1 KINASE; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL CYCLE; GENE OVEREXPRESSION; GROWTH INHIBITION; NERVE CELL DIFFERENTIATION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ADENOVIRUS; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; GENE TRANSFER; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; STEM CELL; WESTERN BLOTTING;

ADENOVIRIDAE; ANTIMETABOLITES; BLOTTING, WESTERN; BROMODEOXYURIDINE; CDC2-CDC28 KINASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; OLIGODENDROGLIA; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; STEM CELLS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032486850     PISSN: 00223034     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4695(19980905)36:3<431::AID-NEU10>3.0.CO;2-E     Document Type: Article

References (25)

1. BARRES. B., LAZAR, M., and RAFF, M. (1994). A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing of oligodendrocyte development. Development 120:1097-1108.
2. CASACCIA-BONNEFIL, P., AIBEL, L., and CHAO. M. V. (1996). Central glial and neuronal populations display differential sensitivity to ceramide-dependent cell death. J. Neurosci. Res. 43:382-389.
3. Kipl. Genes Dev. 11:2335-2346.
4. CRAIG, C., WERSTO, R., KIM, M., OHRI, E., Li, Z., KATAYOSE, D., LEE, S. J., TREPEL, J., COWAN, K., and SETH, P. (1997). Recombinant adenovirus expressing p27Kipl induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene 14:2283-2289.
5. Cipl/Wafl in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 280:1069-1072.
6. DURAND, B., GAO, F.-B., and RAFF, M. (1997). Accumulation of the cyclin-dependent kinase inhibitor p27/ Kip 1 and the timing of oligodendrocyte differentiation. EMBO J. 16:306-317.
7. FISHER, R. and MORGAN, D. (1994). A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78:713-724.
8. GARD, A. L. and PFEIFFER, S. E. (1990). Two proliferative stages of the oligodendrocyte lineage (A2B5 +04- and 04+GalC-) under different mitogenic control. Neuron 5:615-625.
9. HALEVY, O., NOVITCH, B. G., SPICER, D. B., SKAPEK, S. X., RHEE, J., HANNON, G. J., BEACH, D., and LASSAR, A. B. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21. Science 267:1018-1021.
10. IBARROLA, N., MAYER-PROSCHEL, M., RODRIGUEZ-PENA, A., and NOBLE, M. (1996). Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. Dev. Biol. 180:1-21.
11. LOUIS, J., MAGAL, E., MUIR, D., MANTHORPE, M., and VARON, S. (1992). CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J. Neurosci. Res. 31:193-204.
12. ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA 92:6289-6293.
13. NOBLE, M., MURRAY, K., STROOBANT, P., WATERFIELD, M. D., and RIDDLE, P. (1988). Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333:560-562.
14. PFEIFFER, S. E., WARRINGTON, A. E., and BANSAL, R. (1993). The oligodendrocyte and its many processes. Trends Cell Biol. 3:191-197.
15. RAFF, M. C. (1989). Glial cell diversification in the rat optic nerve. Nature 243:1450-1455.
16. RAFF, M. C., ABNEY, E. R., and FOK-SEANG, J. (1985). Reconstitution of a developmental clock in vitro: a critical role for astrocytes in the timing of oligodendrocyte differentiation. Cell 42:61-69.
17. RAFF, M. C., LILLIEN, L. E., RICHARDSON, W. D., BURNE, J. F., and NOBLE, M. D. (1988). Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333:562-565.
18. RAFF, M. C., MILLER, R. H., and NOBLE, M. (1983). A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303:390-396.
19. Kipl cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382:325-331.
20. SHERR, C. (1994). G1 phase progression: cycling on cue. Cell 78:551-555.
21. SHERR, C. J. (1993). Mammalian G1 cyclins. Cell 73:1059-1065.
22. SHERR, C. J. and ROBERTS, J. M. (1995). Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 79:551-555.
23. SOMMER, I. and SCHACHMER, M. (1981). Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev. Biol. 83:311-327.
24. TEMPLE, S. and RAFF, M. C. (1985). Differentiation of a bipotential glial progenitor cell in single cell microculture. Nature 313:223-225.
25. Kip accompany glial cell differentiation of central glial-4 cells. J. Biol. Chem. 272:442-447.